NCT06854198 Glaucoma Screening to Enhance At-Risk Californians' Health
| NCT ID | NCT06854198 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Glaucoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2026-02-10 |
| Primary Completion | 2029-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,000 participants in total. It began in 2026-02-10 with a primary completion date of 2029-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The vast majority of glaucoma cases in the United States go undetected and untreated until the late stages of the disease. Open-angle glaucoma is a progressive condition that is asymptomatic in its early to moderate stages and may be amenable to screening through telemedicine-based approaches. This study is a randomized trial to evaluate whether glaucoma screening with established tests (e.g., optical coherence tomography, fundus photography, and tonometry) is more effective for detecting undiagnosed glaucoma cases compared to education alone or delayed intervention.
Eligibility Criteria
Inclusion Criteria: * Black people aged 50 years or older * Hispanic people aged 65 years or older * People with diabetes aged 50 years or older * Must have been seen at the Federally Qualified Health Center (FQHC) within the past month Exclusion Criteria: * Patients without a valid phone number or mailing address * Patients who have had an optometry appointment within the past year
Contact & Investigator
Jeremy D Keenan, MD, MPH
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06854198 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Glaucoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06854198 currently recruiting?
Yes, NCT06854198 is actively recruiting participants. Contact the research team at dionna.wittberg@ucsf.edu for enrollment information.
Where is the NCT06854198 trial being conducted?
This trial is being conducted at Fremont, United States, Oakland, United States, San Francisco, United States.
Who is sponsoring the NCT06854198 clinical trial?
NCT06854198 is sponsored by University of California, San Francisco. The principal investigator is Jeremy D Keenan, MD, MPH at University of California, San Francisco. The trial plans to enroll 2,000 participants.